GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use.
Curr Obes Rep
; 12(2): 61-74, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37081371
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Diabetes Mellitus, Type 2
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Curr Obes Rep
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: